Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol
Ara mostrant els elements 3731-3750 d 4260
-
T1w/FLAIR ratio standardization as a myelin marker in MS patients
(Elsevier, 2022) -
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
(Ferrata Storti Foundation, 2024-02) -
Tailoring of the photocatalytic activity of CeO2 nanoparticles by the presence of plasmonic Ag nanoparticles
(Royal Society of Chemistry, 2022-07-27) -
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design
(Future Medicine, 2022-02) -
Tallers d’educació afectiva i sexual a l’ESO
(Institut Català de la Salut, 2021-05) -
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
(Nature Publishing Group, 2019-09-19) -
Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies
(Wiley Online Library, 2019-07-24) -
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
(MDPI, 2021-08-24) -
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
(American Association for the Advancement of Science, 2022-05-20) -
Targeting HIV persistence in the tissue
(Wolters Kluwer Health, 2024) -
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models
(Nature Portfolio, 2023-02-15) -
Targeting MYC-driven lymphoma: lessons learned and future directions
(OAE Publishing, 2023-04-12) -
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
(Nature Research, 2021-06-01) -
Targeting Sphingolipids for Cancer Therapy
(Frontiers Media, 2021-10-19)